Dr. Joshua M. Sharfstein, associate dean for public health practice and training at the Johns Hopkins Bloomberg School of Public Health, has been named inaugural director of the school’s Bloomberg American Health Initiative, which was launched in September with a $300 million gift from Bloomberg Philanthropies.
Joining Dr. Sharfstein will be Ms. Michelle L. Spencer, director of the Prevention & Health Promotion Administration at the Maryland Department of Health and Mental Hygiene, who has been named the initiative’s associate director.
“The Bloomberg American Health Initiative is the outgrowth of an unprecedented investment from our School’s namesake, philanthropist and former New York City mayor Michael R. Bloomberg, designed to develop innovative solutions to the health threats facing the United States in the 21st century,” says Dean Michael J. Klag. “We could think of no one better to lead this project than Josh Sharfstein, who will help us create the building blocks needed to get us to this ambitious goal of transforming the national response to modern public health challenges.”
Dr. Sharfstein came to Johns Hopkins in 2015 after serving as secretary of the Maryland Department of Health and Mental Hygiene. He was previously the principal deputy commissioner of the U.S. Food and Drug Administration, the Baltimore City’s commissioner of health and a health policy advisor for former Congressman Henry A. Waxman. He earned his medical degree from Harvard Medical School. Dr. Sharfstein will continue to serve as associate dean and professor of the practice in the department of health policy and management, in addition to the new position.